CRL vs XXII · rev $4.02B vs rev $7.0M
Charles River Laboratories (CRL) versus 22nd Century Group Inc (XXII) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
22nd Century Group Inc (XXII) is a tobacco company listed on NASDAQ.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
Latest reported XXII revenue for 2026-06-30 was $7.0M. Net income was -$6.6M. Revenue was up 69.8% from 2026-03-31 to 2026-06-30. XXII currently screens at market cap $1.9M.
CRL currently screens at market cap $7.78B. XXII currently screens at market cap $1.9M.
Not investment advice. Open the CRL and XXII stock pages for the full models.
Not investment advice.